Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
215 |
788 |
5.155e-37 |
1.199e-33 |
2 |
CIRCULATORY SYSTEM DEVELOPMENT |
215 |
788 |
5.155e-37 |
1.199e-33 |
3 |
TISSUE DEVELOPMENT |
324 |
1518 |
2.205e-32 |
3.419e-29 |
4 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
195 |
771 |
7.205e-29 |
8.381e-26 |
5 |
BIOLOGICAL ADHESION |
236 |
1032 |
6.831e-28 |
6.357e-25 |
6 |
CELL DEVELOPMENT |
296 |
1426 |
2.351e-27 |
1.823e-24 |
7 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
331 |
1672 |
9.016e-27 |
5.993e-24 |
8 |
LOCOMOTION |
245 |
1114 |
2.56e-26 |
1.489e-23 |
9 |
VASCULATURE DEVELOPMENT |
135 |
469 |
7.254e-26 |
3.75e-23 |
10 |
REGULATION OF CELL DIFFERENTIATION |
299 |
1492 |
5.237e-25 |
2.437e-22 |
11 |
HEART DEVELOPMENT |
132 |
466 |
1.351e-24 |
5.715e-22 |
12 |
NEUROGENESIS |
283 |
1402 |
3.757e-24 |
1.457e-21 |
13 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
263 |
1275 |
7.478e-24 |
2.676e-21 |
14 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
222 |
1021 |
3.475e-23 |
1.155e-20 |
15 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
211 |
957 |
7.671e-23 |
2.38e-20 |
16 |
ORGAN MORPHOGENESIS |
189 |
841 |
1.689e-21 |
4.913e-19 |
17 |
EPITHELIUM DEVELOPMENT |
205 |
945 |
2.555e-21 |
6.993e-19 |
18 |
INTRACELLULAR SIGNAL TRANSDUCTION |
297 |
1572 |
1.016e-20 |
2.627e-18 |
19 |
TISSUE MORPHOGENESIS |
135 |
533 |
2.753e-20 |
6.742e-18 |
20 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
264 |
1360 |
4.667e-20 |
1.086e-17 |
21 |
CELL MOTILITY |
184 |
835 |
5.711e-20 |
1.208e-17 |
22 |
LOCALIZATION OF CELL |
184 |
835 |
5.711e-20 |
1.208e-17 |
23 |
BLOOD VESSEL MORPHOGENESIS |
104 |
364 |
6.408e-20 |
1.265e-17 |
24 |
NEURON DIFFERENTIATION |
190 |
874 |
6.522e-20 |
1.265e-17 |
25 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
129 |
513 |
3.773e-19 |
7.022e-17 |
26 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
236 |
1192 |
4.669e-19 |
8.355e-17 |
27 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
303 |
1656 |
5.342e-19 |
9.206e-17 |
28 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
227 |
1142 |
1.457e-18 |
2.421e-16 |
29 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
263 |
1395 |
3.125e-18 |
5.013e-16 |
30 |
CELLULAR COMPONENT MORPHOGENESIS |
189 |
900 |
4.046e-18 |
6.275e-16 |
31 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
337 |
1929 |
6.668e-18 |
1.001e-15 |
32 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
322 |
1848 |
6.265e-17 |
9.109e-15 |
33 |
MORPHOGENESIS OF AN EPITHELIUM |
104 |
400 |
9.744e-17 |
1.374e-14 |
34 |
REGULATION OF CELL PROLIFERATION |
272 |
1496 |
1.057e-16 |
1.447e-14 |
35 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
289 |
1618 |
1.174e-16 |
1.561e-14 |
36 |
RESPONSE TO ENDOGENOUS STIMULUS |
265 |
1450 |
1.429e-16 |
1.847e-14 |
37 |
POSITIVE REGULATION OF LOCOMOTION |
107 |
420 |
1.639e-16 |
2.062e-14 |
38 |
REGULATION OF CELL DEVELOPMENT |
174 |
836 |
2.333e-16 |
2.857e-14 |
39 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
200 |
1008 |
2.395e-16 |
2.858e-14 |
40 |
NEURON DEVELOPMENT |
150 |
687 |
4.39e-16 |
5.106e-14 |
41 |
CELL CELL ADHESION |
137 |
608 |
6.099e-16 |
6.922e-14 |
42 |
POSITIVE REGULATION OF CELL COMMUNICATION |
274 |
1532 |
6.997e-16 |
7.752e-14 |
43 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
167 |
801 |
8.247e-16 |
8.924e-14 |
44 |
TUBE DEVELOPMENT |
127 |
552 |
1.37e-15 |
1.417e-13 |
45 |
REGULATION OF CELL MORPHOGENESIS |
127 |
552 |
1.37e-15 |
1.417e-13 |
46 |
POSITIVE REGULATION OF GENE EXPRESSION |
300 |
1733 |
2.155e-15 |
2.18e-13 |
47 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
193 |
983 |
2.505e-15 |
2.48e-13 |
48 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
148 |
689 |
2.974e-15 |
2.883e-13 |
49 |
MUSCLE STRUCTURE DEVELOPMENT |
106 |
432 |
3.585e-15 |
3.405e-13 |
50 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
307 |
1791 |
3.694e-15 |
3.437e-13 |
51 |
CELL PROJECTION ORGANIZATION |
180 |
902 |
4.813e-15 |
4.391e-13 |
52 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
308 |
1805 |
6.124e-15 |
5.479e-13 |
53 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
94 |
368 |
9.724e-15 |
8.537e-13 |
54 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
167 |
823 |
1.072e-14 |
9.236e-13 |
55 |
NEURON PROJECTION DEVELOPMENT |
123 |
545 |
1.742e-14 |
1.473e-12 |
56 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
193 |
1004 |
2.161e-14 |
1.796e-12 |
57 |
UROGENITAL SYSTEM DEVELOPMENT |
81 |
299 |
2.205e-14 |
1.8e-12 |
58 |
NEURON PROJECTION MORPHOGENESIS |
99 |
402 |
2.312e-14 |
1.855e-12 |
59 |
REGULATION OF CELL ADHESION |
136 |
629 |
2.441e-14 |
1.925e-12 |
60 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
302 |
1784 |
3.384e-14 |
2.624e-12 |
61 |
REGULATION OF CELL DEATH |
259 |
1472 |
3.529e-14 |
2.692e-12 |
62 |
EMBRYO DEVELOPMENT |
176 |
894 |
3.603e-14 |
2.704e-12 |
63 |
REGULATION OF TRANSPORT |
304 |
1804 |
4.972e-14 |
3.672e-12 |
64 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
196 |
1036 |
6.665e-14 |
4.771e-12 |
65 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
196 |
1036 |
6.665e-14 |
4.771e-12 |
66 |
REGULATION OF OSSIFICATION |
57 |
178 |
8.064e-14 |
5.685e-12 |
67 |
TAXIS |
108 |
464 |
8.59e-14 |
5.966e-12 |
68 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
325 |
1977 |
1.647e-13 |
1.115e-11 |
69 |
HEAD DEVELOPMENT |
146 |
709 |
1.654e-13 |
1.115e-11 |
70 |
ANGIOGENESIS |
78 |
293 |
1.823e-13 |
1.212e-11 |
71 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
262 |
1518 |
2.403e-13 |
1.559e-11 |
72 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
243 |
1381 |
2.412e-13 |
1.559e-11 |
73 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
159 |
799 |
2.654e-13 |
1.691e-11 |
74 |
REGULATION OF NEURON DIFFERENTIATION |
121 |
554 |
3.286e-13 |
2.066e-11 |
75 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
151 |
750 |
4.164e-13 |
2.584e-11 |
76 |
MUSCLE TISSUE DEVELOPMENT |
74 |
275 |
4.231e-13 |
2.591e-11 |
77 |
IMMUNE SYSTEM PROCESS |
324 |
1984 |
4.34e-13 |
2.623e-11 |
78 |
RESPONSE TO EXTERNAL STIMULUS |
302 |
1821 |
4.706e-13 |
2.807e-11 |
79 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
169 |
872 |
4.89e-13 |
2.88e-11 |
80 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
286 |
1710 |
7.947e-13 |
4.622e-11 |
81 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
78 |
304 |
1.44e-12 |
8.272e-11 |
82 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
133 |
643 |
1.482e-12 |
8.408e-11 |
83 |
REGULATION OF KINASE ACTIVITY |
153 |
776 |
1.642e-12 |
9.205e-11 |
84 |
CELL PART MORPHOGENESIS |
131 |
633 |
2.111e-12 |
1.169e-10 |
85 |
HOMEOSTATIC PROCESS |
233 |
1337 |
2.205e-12 |
1.207e-10 |
86 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
127 |
609 |
2.662e-12 |
1.44e-10 |
87 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
253 |
1492 |
4.624e-12 |
2.473e-10 |
88 |
NEURON PROJECTION GUIDANCE |
59 |
205 |
4.902e-12 |
2.592e-10 |
89 |
RESPONSE TO GROWTH FACTOR |
105 |
475 |
5.764e-12 |
3.014e-10 |
90 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
63 |
229 |
8.212e-12 |
4.246e-10 |
91 |
ACTIN FILAMENT BASED PROCESS |
100 |
450 |
1.34e-11 |
6.85e-10 |
92 |
EMBRYONIC MORPHOGENESIS |
114 |
539 |
1.417e-11 |
7.168e-10 |
93 |
GLAND DEVELOPMENT |
91 |
395 |
1.436e-11 |
7.186e-10 |
94 |
CHEMICAL HOMEOSTASIS |
164 |
874 |
1.666e-11 |
8.246e-10 |
95 |
REGULATION OF CELLULAR LOCALIZATION |
221 |
1277 |
1.72e-11 |
8.425e-10 |
96 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
201 |
1135 |
1.928e-11 |
9.344e-10 |
97 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
103 |
472 |
2.059e-11 |
9.777e-10 |
98 |
TELENCEPHALON DEVELOPMENT |
62 |
228 |
2.057e-11 |
9.777e-10 |
99 |
HEART MORPHOGENESIS |
59 |
212 |
2.245e-11 |
1.055e-09 |
100 |
RESPONSE TO WOUNDING |
117 |
563 |
2.485e-11 |
1.156e-09 |
101 |
GLAND MORPHOGENESIS |
36 |
97 |
2.632e-11 |
1.212e-09 |
102 |
TUBE MORPHOGENESIS |
78 |
323 |
3.727e-11 |
1.7e-09 |
103 |
REGULATION OF CELL PROJECTION ORGANIZATION |
115 |
558 |
6.348e-11 |
2.868e-09 |
104 |
STEM CELL DIFFERENTIATION |
54 |
190 |
6.574e-11 |
2.941e-09 |
105 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
96 |
437 |
6.768e-11 |
2.999e-09 |
106 |
FOREBRAIN DEVELOPMENT |
83 |
357 |
6.965e-11 |
3.057e-09 |
107 |
CARDIAC CHAMBER DEVELOPMENT |
45 |
144 |
8.205e-11 |
3.568e-09 |
108 |
SINGLE ORGANISM CELL ADHESION |
99 |
459 |
1.013e-10 |
4.366e-09 |
109 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
93 |
422 |
1.124e-10 |
4.797e-09 |
110 |
REGULATION OF DEVELOPMENTAL GROWTH |
71 |
289 |
1.229e-10 |
5.198e-09 |
111 |
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
69 |
278 |
1.381e-10 |
5.789e-09 |
112 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
141 |
740 |
1.575e-10 |
6.541e-09 |
113 |
NEGATIVE REGULATION OF CELL DEATH |
160 |
872 |
1.734e-10 |
7.141e-09 |
114 |
REGULATION OF MAPK CASCADE |
129 |
660 |
1.772e-10 |
7.232e-09 |
115 |
PROTEIN PHOSPHORYLATION |
170 |
944 |
2.054e-10 |
8.309e-09 |
116 |
MESENCHYME DEVELOPMENT |
53 |
190 |
2.101e-10 |
8.429e-09 |
117 |
IMMUNE SYSTEM DEVELOPMENT |
117 |
582 |
2.172e-10 |
8.639e-09 |
118 |
EPITHELIAL CELL DEVELOPMENT |
52 |
186 |
2.842e-10 |
1.121e-08 |
119 |
MESENCHYMAL CELL DIFFERENTIATION |
42 |
134 |
3.122e-10 |
1.221e-08 |
120 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
78 |
337 |
3.255e-10 |
1.262e-08 |
121 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
69 |
285 |
4.421e-10 |
1.7e-08 |
122 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
99 |
472 |
5.108e-10 |
1.948e-08 |
123 |
SENSORY ORGAN DEVELOPMENT |
102 |
493 |
6.182e-10 |
2.338e-08 |
124 |
REGULATION OF GTPASE ACTIVITY |
129 |
673 |
6.557e-10 |
2.461e-08 |
125 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
73 |
312 |
7.184e-10 |
2.674e-08 |
126 |
POSITIVE REGULATION OF KINASE ACTIVITY |
100 |
482 |
7.791e-10 |
2.837e-08 |
127 |
SALIVARY GLAND DEVELOPMENT |
18 |
32 |
7.748e-10 |
2.837e-08 |
128 |
EPITHELIAL CELL DIFFERENTIATION |
102 |
495 |
7.805e-10 |
2.837e-08 |
129 |
EMBRYONIC ORGAN DEVELOPMENT |
88 |
406 |
8.592e-10 |
3.099e-08 |
130 |
REGULATION OF HYDROLASE ACTIVITY |
220 |
1327 |
1.065e-09 |
3.812e-08 |
131 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
88 |
408 |
1.112e-09 |
3.949e-08 |
132 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
47 |
166 |
1.277e-09 |
4.502e-08 |
133 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
157 |
876 |
1.488e-09 |
5.206e-08 |
134 |
KIDNEY EPITHELIUM DEVELOPMENT |
39 |
125 |
1.54e-09 |
5.349e-08 |
135 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
108 |
541 |
1.635e-09 |
5.594e-08 |
136 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
108 |
541 |
1.635e-09 |
5.594e-08 |
137 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
141 |
767 |
1.931e-09 |
6.558e-08 |
138 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
54 |
207 |
2.059e-09 |
6.941e-08 |
139 |
DEVELOPMENTAL GROWTH |
75 |
333 |
2.59e-09 |
8.669e-08 |
140 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
36 |
112 |
2.643e-09 |
8.785e-08 |
141 |
EXOCRINE SYSTEM DEVELOPMENT |
21 |
45 |
2.782e-09 |
9.179e-08 |
142 |
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT |
27 |
70 |
2.929e-09 |
9.596e-08 |
143 |
SKELETAL SYSTEM DEVELOPMENT |
94 |
455 |
3.149e-09 |
1.025e-07 |
144 |
REGULATION OF PROTEIN LOCALIZATION |
166 |
950 |
3.344e-09 |
1.081e-07 |
145 |
ION HOMEOSTASIS |
112 |
576 |
3.9e-09 |
1.252e-07 |
146 |
RESPONSE TO LIPID |
157 |
888 |
3.968e-09 |
1.265e-07 |
147 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
41 |
140 |
4.826e-09 |
1.517e-07 |
148 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
100 |
498 |
4.795e-09 |
1.517e-07 |
149 |
PHOSPHORYLATION |
203 |
1228 |
6.318e-09 |
1.973e-07 |
150 |
RESPONSE TO ABIOTIC STIMULUS |
175 |
1024 |
6.702e-09 |
2.079e-07 |
151 |
GROWTH |
86 |
410 |
6.975e-09 |
2.149e-07 |
152 |
WOUND HEALING |
95 |
470 |
8.258e-09 |
2.511e-07 |
153 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
95 |
470 |
8.258e-09 |
2.511e-07 |
154 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
158 |
905 |
8.646e-09 |
2.612e-07 |
155 |
REGULATION OF JNK CASCADE |
44 |
159 |
9.165e-09 |
2.751e-07 |
156 |
NEGATIVE REGULATION OF LOCOMOTION |
62 |
263 |
9.985e-09 |
2.978e-07 |
157 |
RESPONSE TO HORMONE |
156 |
893 |
1.034e-08 |
3.064e-07 |
158 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
69 |
306 |
1.057e-08 |
3.113e-07 |
159 |
NEGATIVE REGULATION OF GENE EXPRESSION |
237 |
1493 |
1.251e-08 |
3.66e-07 |
160 |
REGULATION OF SYSTEM PROCESS |
100 |
507 |
1.258e-08 |
3.66e-07 |
161 |
REGULATION OF TRANSFERASE ACTIVITY |
163 |
946 |
1.275e-08 |
3.686e-07 |
162 |
MUSCLE ORGAN DEVELOPMENT |
64 |
277 |
1.333e-08 |
3.817e-07 |
163 |
REGULATION OF CYTOPLASMIC TRANSPORT |
96 |
481 |
1.337e-08 |
3.817e-07 |
164 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
76 |
352 |
1.435e-08 |
4.071e-07 |
165 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
191 |
1152 |
1.46e-08 |
4.116e-07 |
166 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
89 |
437 |
1.681e-08 |
4.712e-07 |
167 |
MUSCLE CELL DIFFERENTIATION |
57 |
237 |
1.828e-08 |
5.094e-07 |
168 |
REGULATION OF GROWTH |
118 |
633 |
1.856e-08 |
5.142e-07 |
169 |
MESONEPHROS DEVELOPMENT |
30 |
90 |
2.143e-08 |
5.9e-07 |
170 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
158 |
917 |
2.156e-08 |
5.901e-07 |
171 |
REGULATION OF BODY FLUID LEVELS |
99 |
506 |
2.272e-08 |
6.182e-07 |
172 |
REGULATION OF CELLULAR COMPONENT SIZE |
73 |
337 |
2.388e-08 |
6.46e-07 |
173 |
REGULATION OF VASCULATURE DEVELOPMENT |
56 |
233 |
2.492e-08 |
6.703e-07 |
174 |
CELL ACTIVATION |
108 |
568 |
2.569e-08 |
6.871e-07 |
175 |
RESPONSE TO MECHANICAL STIMULUS |
52 |
210 |
2.724e-08 |
7.242e-07 |
176 |
DIGESTIVE SYSTEM DEVELOPMENT |
41 |
148 |
2.807e-08 |
7.42e-07 |
177 |
POSITIVE REGULATION OF CELL PROLIFERATION |
143 |
814 |
3.032e-08 |
7.97e-07 |
178 |
NEGATIVE REGULATION OF CELL ADHESION |
54 |
223 |
3.356e-08 |
8.774e-07 |
179 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
92 |
465 |
4.123e-08 |
1.072e-06 |
180 |
RESPONSE TO INORGANIC SUBSTANCE |
94 |
479 |
4.422e-08 |
1.143e-06 |
181 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
32 |
103 |
4.945e-08 |
1.271e-06 |
182 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
49 |
197 |
5.835e-08 |
1.484e-06 |
183 |
RESPIRATORY SYSTEM DEVELOPMENT |
49 |
197 |
5.835e-08 |
1.484e-06 |
184 |
BEHAVIOR |
99 |
516 |
6.216e-08 |
1.572e-06 |
185 |
POSITIVE REGULATION OF OSSIFICATION |
28 |
84 |
6.271e-08 |
1.577e-06 |
186 |
CARDIAC CHAMBER MORPHOGENESIS |
32 |
104 |
6.378e-08 |
1.587e-06 |
187 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
32 |
104 |
6.378e-08 |
1.587e-06 |
188 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
31 |
99 |
6.509e-08 |
1.602e-06 |
189 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
31 |
99 |
6.509e-08 |
1.602e-06 |
190 |
EYE DEVELOPMENT |
70 |
326 |
6.638e-08 |
1.626e-06 |
191 |
POSITIVE REGULATION OF MAPK CASCADE |
92 |
470 |
6.949e-08 |
1.693e-06 |
192 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
157 |
926 |
7.058e-08 |
1.71e-06 |
193 |
NEURAL CREST CELL DIFFERENTIATION |
26 |
75 |
7.483e-08 |
1.804e-06 |
194 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
236 |
1517 |
7.615e-08 |
1.817e-06 |
195 |
REGULATION OF INTRACELLULAR TRANSPORT |
114 |
621 |
7.586e-08 |
1.817e-06 |
196 |
PALLIUM DEVELOPMENT |
41 |
153 |
7.75e-08 |
1.84e-06 |
197 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
97 |
505 |
7.975e-08 |
1.874e-06 |
198 |
DEVELOPMENTAL MATURATION |
48 |
193 |
7.963e-08 |
1.874e-06 |
199 |
CARDIAC SEPTUM DEVELOPMENT |
28 |
85 |
8.355e-08 |
1.954e-06 |
200 |
ENDOTHELIUM DEVELOPMENT |
29 |
90 |
8.528e-08 |
1.984e-06 |
201 |
RESPONSE TO NITROGEN COMPOUND |
147 |
859 |
1.046e-07 |
2.414e-06 |
202 |
CARDIAC VENTRICLE DEVELOPMENT |
32 |
106 |
1.048e-07 |
2.414e-06 |
203 |
REGULATION OF EPITHELIAL CELL MIGRATION |
43 |
166 |
1.085e-07 |
2.487e-06 |
204 |
CYTOSKELETON ORGANIZATION |
144 |
838 |
1.097e-07 |
2.501e-06 |
205 |
EMBRYONIC DIGESTIVE TRACT DEVELOPMENT |
16 |
33 |
1.114e-07 |
2.528e-06 |
206 |
REGULATION OF CELL SIZE |
44 |
172 |
1.147e-07 |
2.59e-06 |
207 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
39 |
144 |
1.174e-07 |
2.639e-06 |
208 |
REGULATION OF VESICLE MEDIATED TRANSPORT |
90 |
462 |
1.209e-07 |
2.692e-06 |
209 |
POSITIVE REGULATION OF CELL ADHESION |
77 |
376 |
1.209e-07 |
2.692e-06 |
210 |
CELLULAR HOMEOSTASIS |
121 |
676 |
1.273e-07 |
2.82e-06 |
211 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
43 |
167 |
1.304e-07 |
2.876e-06 |
212 |
REGULATION OF CELL SUBSTRATE ADHESION |
44 |
173 |
1.372e-07 |
3.012e-06 |
213 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
103 |
552 |
1.423e-07 |
3.108e-06 |
214 |
RESPONSE TO OXIDATIVE STRESS |
73 |
352 |
1.52e-07 |
3.306e-06 |
215 |
CELL JUNCTION ASSEMBLY |
36 |
129 |
1.577e-07 |
3.413e-06 |
216 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
65 |
303 |
2.005e-07 |
4.319e-06 |
217 |
VESICLE MEDIATED TRANSPORT |
197 |
1239 |
2.095e-07 |
4.493e-06 |
218 |
CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS |
14 |
27 |
2.411e-07 |
5.145e-06 |
219 |
LEUKOCYTE DIFFERENTIATION |
63 |
292 |
2.479e-07 |
5.268e-06 |
220 |
NEPHRON DEVELOPMENT |
33 |
115 |
2.515e-07 |
5.319e-06 |
221 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
102 |
552 |
2.659e-07 |
5.597e-06 |
222 |
REGULATION OF IMMUNE SYSTEM PROCESS |
218 |
1403 |
2.752e-07 |
5.768e-06 |
223 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
34 |
121 |
2.888e-07 |
6.025e-06 |
224 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
111 |
616 |
2.989e-07 |
6.209e-06 |
225 |
NEGATIVE CHEMOTAXIS |
17 |
39 |
3.108e-07 |
6.427e-06 |
226 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
102 |
554 |
3.178e-07 |
6.543e-06 |
227 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
45 |
184 |
3.355e-07 |
6.877e-06 |
228 |
CELL DEATH |
164 |
1001 |
3.519e-07 |
7.181e-06 |
229 |
TRANSITION METAL ION HOMEOSTASIS |
31 |
106 |
3.624e-07 |
7.363e-06 |
230 |
STRIATED MUSCLE CELL DIFFERENTIATION |
43 |
173 |
3.771e-07 |
7.628e-06 |
231 |
BONE DEVELOPMENT |
40 |
156 |
3.973e-07 |
7.969e-06 |
232 |
CELL JUNCTION ORGANIZATION |
45 |
185 |
3.957e-07 |
7.969e-06 |
233 |
REGULATION OF HOMEOSTATIC PROCESS |
86 |
447 |
4.002e-07 |
7.993e-06 |
234 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
41 |
162 |
4.168e-07 |
8.287e-06 |
235 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
64 |
303 |
4.437e-07 |
8.785e-06 |
236 |
REGULATION OF CHEMOTAXIS |
44 |
180 |
4.578e-07 |
9.026e-06 |
237 |
LEUKOCYTE MIGRATION |
57 |
259 |
4.602e-07 |
9.036e-06 |
238 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
78 |
395 |
4.725e-07 |
9.237e-06 |
239 |
APPENDAGE DEVELOPMENT |
42 |
169 |
5.147e-07 |
9.979e-06 |
240 |
LIMB DEVELOPMENT |
42 |
169 |
5.147e-07 |
9.979e-06 |
241 |
SMOOTH MUSCLE TISSUE DEVELOPMENT |
11 |
18 |
5.339e-07 |
1.03e-05 |
242 |
CELL GROWTH |
36 |
135 |
5.357e-07 |
1.03e-05 |
243 |
LOCOMOTORY BEHAVIOR |
44 |
181 |
5.399e-07 |
1.034e-05 |
244 |
REGULATION OF ORGAN MORPHOGENESIS |
54 |
242 |
5.778e-07 |
1.102e-05 |
245 |
SINGLE ORGANISM BEHAVIOR |
76 |
384 |
6.02e-07 |
1.143e-05 |
246 |
REGULATION OF METAL ION TRANSPORT |
67 |
325 |
6.098e-07 |
1.153e-05 |
247 |
POSITIVE REGULATION OF TRANSPORT |
154 |
936 |
6.263e-07 |
1.18e-05 |
248 |
REGULATION OF MAP KINASE ACTIVITY |
66 |
319 |
6.451e-07 |
1.21e-05 |
249 |
HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
39 |
153 |
6.497e-07 |
1.214e-05 |
250 |
CELLULAR CHEMICAL HOMEOSTASIS |
103 |
570 |
6.959e-07 |
1.295e-05 |
251 |
VENTRICULAR SEPTUM DEVELOPMENT |
20 |
54 |
7.005e-07 |
1.299e-05 |
252 |
REGULATION OF PROTEIN IMPORT |
44 |
183 |
7.467e-07 |
1.379e-05 |
253 |
MYELOID CELL DIFFERENTIATION |
45 |
189 |
7.526e-07 |
1.384e-05 |
254 |
AMEBOIDAL TYPE CELL MIGRATION |
39 |
154 |
7.768e-07 |
1.423e-05 |
255 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
52 |
232 |
8.037e-07 |
1.467e-05 |
256 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
61 |
289 |
8.393e-07 |
1.525e-05 |
257 |
CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS |
12 |
22 |
8.727e-07 |
1.58e-05 |
258 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
45 |
190 |
8.801e-07 |
1.587e-05 |
259 |
PLASMA MEMBRANE ORGANIZATION |
47 |
203 |
1.016e-06 |
1.826e-05 |
260 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
35 |
133 |
1.074e-06 |
1.923e-05 |
261 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
33 |
122 |
1.108e-06 |
1.968e-05 |
262 |
REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS |
28 |
95 |
1.104e-06 |
1.968e-05 |
263 |
REGULATION OF CELL SHAPE |
36 |
139 |
1.147e-06 |
2.029e-05 |
264 |
HEMOSTASIS |
64 |
311 |
1.151e-06 |
2.029e-05 |
265 |
CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
47 |
204 |
1.179e-06 |
2.069e-05 |
266 |
COLLAGEN FIBRIL ORGANIZATION |
16 |
38 |
1.223e-06 |
2.131e-05 |
267 |
POSITIVE REGULATION OF CELL DEATH |
107 |
605 |
1.222e-06 |
2.131e-05 |
268 |
RESPONSE TO FLUID SHEAR STRESS |
15 |
34 |
1.282e-06 |
2.217e-05 |
269 |
CAMP METABOLIC PROCESS |
15 |
34 |
1.282e-06 |
2.217e-05 |
270 |
GLIOGENESIS |
42 |
175 |
1.389e-06 |
2.394e-05 |
271 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
49 |
218 |
1.514e-06 |
2.599e-05 |
272 |
REGULATION OF LIPID METABOLIC PROCESS |
59 |
282 |
1.704e-06 |
2.914e-05 |
273 |
REGULATION OF BLOOD CIRCULATION |
61 |
295 |
1.722e-06 |
2.935e-05 |
274 |
RESPONSE TO STEROID HORMONE |
91 |
497 |
1.736e-06 |
2.948e-05 |
275 |
PROTEIN LOCALIZATION |
265 |
1805 |
1.761e-06 |
2.98e-05 |
276 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
51 |
232 |
1.878e-06 |
3.159e-05 |
277 |
REGULATION OF MUSCLE SYSTEM PROCESS |
45 |
195 |
1.88e-06 |
3.159e-05 |
278 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
22 |
67 |
2.115e-06 |
3.528e-05 |
279 |
REGULATION OF BMP SIGNALING PATHWAY |
24 |
77 |
2.123e-06 |
3.528e-05 |
280 |
DEVELOPMENTAL CELL GROWTH |
24 |
77 |
2.123e-06 |
3.528e-05 |
281 |
ENDOTHELIAL CELL DIFFERENTIATION |
23 |
72 |
2.143e-06 |
3.548e-05 |
282 |
PROTEIN DEPHOSPHORYLATION |
44 |
190 |
2.205e-06 |
3.638e-05 |
283 |
REGULATION OF RESPONSE TO STRESS |
221 |
1468 |
2.416e-06 |
3.973e-05 |
284 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
44 |
191 |
2.557e-06 |
4.19e-05 |
285 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
58 |
279 |
2.57e-06 |
4.196e-05 |
286 |
REGULATION OF CELL JUNCTION ASSEMBLY |
22 |
68 |
2.797e-06 |
4.551e-05 |
287 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
122 |
724 |
2.848e-06 |
4.618e-05 |
288 |
GLOMERULUS DEVELOPMENT |
18 |
49 |
2.877e-06 |
4.649e-05 |
289 |
POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
12 |
24 |
2.939e-06 |
4.716e-05 |
290 |
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
12 |
24 |
2.939e-06 |
4.716e-05 |
291 |
REGULATION OF HEMOPOIESIS |
63 |
314 |
3.371e-06 |
5.39e-05 |
292 |
VASCULOGENESIS |
20 |
59 |
3.493e-06 |
5.566e-05 |
293 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
34 |
134 |
3.693e-06 |
5.864e-05 |
294 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
53 |
250 |
3.744e-06 |
5.926e-05 |
295 |
POSITIVE REGULATION OF GROWTH |
51 |
238 |
4.103e-06 |
6.471e-05 |
296 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
46 |
207 |
4.327e-06 |
6.802e-05 |
297 |
CELL PROLIFERATION |
114 |
672 |
4.367e-06 |
6.841e-05 |
298 |
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
23 |
75 |
4.683e-06 |
7.297e-05 |
299 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
20 |
60 |
4.689e-06 |
7.297e-05 |
300 |
ENDOCYTOSIS |
91 |
509 |
4.811e-06 |
7.437e-05 |
301 |
INOSITOL LIPID MEDIATED SIGNALING |
32 |
124 |
4.797e-06 |
7.437e-05 |
302 |
RHYTHMIC PROCESS |
60 |
298 |
5.087e-06 |
7.837e-05 |
303 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
28 |
102 |
5.157e-06 |
7.919e-05 |
304 |
REGULATION OF RESPONSE TO WOUNDING |
77 |
413 |
5.401e-06 |
8.267e-05 |
305 |
NEURAL CREST CELL MIGRATION |
18 |
51 |
5.57e-06 |
8.497e-05 |
306 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
37 |
154 |
5.601e-06 |
8.517e-05 |
307 |
REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
29 |
108 |
5.68e-06 |
8.608e-05 |
308 |
CIRCULATORY SYSTEM PROCESS |
70 |
366 |
5.789e-06 |
8.746e-05 |
309 |
CELL MATURATION |
33 |
131 |
6.026e-06 |
9.074e-05 |
310 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
76 |
408 |
6.41e-06 |
9.622e-05 |
311 |
REGULATION OF PROTEIN TARGETING |
61 |
307 |
6.604e-06 |
9.88e-05 |
312 |
CELLULAR RESPONSE TO LIPID |
83 |
457 |
6.736e-06 |
0.0001005 |
313 |
KIDNEY MORPHOGENESIS |
24 |
82 |
7.227e-06 |
0.0001074 |
314 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
54 |
262 |
7.304e-06 |
0.0001082 |
315 |
NEGATIVE REGULATION OF TRANSPORT |
83 |
458 |
7.338e-06 |
0.0001082 |
316 |
ENDOMEMBRANE SYSTEM ORGANIZATION |
84 |
465 |
7.348e-06 |
0.0001082 |
317 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
30 |
115 |
7.432e-06 |
0.0001091 |
318 |
CYCLIC NUCLEOTIDE METABOLIC PROCESS |
19 |
57 |
8.067e-06 |
0.000118 |
319 |
FOREBRAIN CELL MIGRATION |
20 |
62 |
8.248e-06 |
0.0001203 |
320 |
REGULATION OF STEM CELL PROLIFERATION |
25 |
88 |
8.414e-06 |
0.0001223 |
321 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
139 |
867 |
8.925e-06 |
0.0001294 |
322 |
PROTEIN LOCALIZATION TO CELL PERIPHERY |
36 |
151 |
8.969e-06 |
0.0001296 |
323 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
54 |
264 |
9.202e-06 |
0.0001322 |
324 |
OSSIFICATION |
52 |
251 |
9.186e-06 |
0.0001322 |
325 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
168 |
1087 |
9.432e-06 |
0.000135 |
326 |
DIGESTIVE TRACT MORPHOGENESIS |
17 |
48 |
9.575e-06 |
0.0001367 |
327 |
TRABECULA MORPHOGENESIS |
15 |
39 |
1.004e-05 |
0.0001428 |
328 |
NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION |
18 |
53 |
1.034e-05 |
0.0001463 |
329 |
MESONEPHRIC TUBULE MORPHOGENESIS |
18 |
53 |
1.034e-05 |
0.0001463 |
330 |
CELL SUBSTRATE ADHESION |
38 |
164 |
1.041e-05 |
0.0001468 |
331 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
47 |
220 |
1.046e-05 |
0.0001471 |
332 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
27 |
100 |
1.055e-05 |
0.0001479 |
333 |
REGULATION OF OSTEOCLAST DIFFERENTIATION |
20 |
63 |
1.082e-05 |
0.0001511 |
334 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
24 |
84 |
1.138e-05 |
0.0001581 |
335 |
EMBRYONIC ORGAN MORPHOGENESIS |
56 |
279 |
1.138e-05 |
0.0001581 |
336 |
REGULATION OF ION TRANSPORT |
101 |
592 |
1.191e-05 |
0.000165 |
337 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
71 |
381 |
1.256e-05 |
0.0001735 |
338 |
REGULATION OF EXTENT OF CELL GROWTH |
27 |
101 |
1.288e-05 |
0.0001773 |
339 |
REGULATION OF CALCIUM ION TRANSPORT |
45 |
209 |
1.296e-05 |
0.0001774 |
340 |
REGULATION OF CELL MATRIX ADHESION |
25 |
90 |
1.295e-05 |
0.0001774 |
341 |
CARDIAC MUSCLE CELL DIFFERENTIATION |
22 |
74 |
1.304e-05 |
0.000178 |
342 |
CELLULAR RESPONSE TO PEPTIDE |
55 |
274 |
1.355e-05 |
0.0001843 |
343 |
PLATELET ACTIVATION |
34 |
142 |
1.426e-05 |
0.0001935 |
344 |
MAMMARY GLAND MORPHOGENESIS |
15 |
40 |
1.44e-05 |
0.0001942 |
345 |
CARDIOCYTE DIFFERENTIATION |
26 |
96 |
1.439e-05 |
0.0001942 |
346 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
74 |
404 |
1.544e-05 |
0.0002077 |
347 |
BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS |
9 |
16 |
1.55e-05 |
0.0002079 |
348 |
APOPTOTIC SIGNALING PATHWAY |
57 |
289 |
1.638e-05 |
0.0002183 |
349 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
32 |
131 |
1.634e-05 |
0.0002183 |
350 |
ARTERY DEVELOPMENT |
22 |
75 |
1.651e-05 |
0.0002196 |
351 |
REGULATION OF MEMBRANE POTENTIAL |
65 |
343 |
1.666e-05 |
0.0002208 |
352 |
REGULATION OF SECRETION |
115 |
699 |
1.672e-05 |
0.000221 |
353 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
58 |
296 |
1.696e-05 |
0.0002236 |
354 |
SEMAPHORIN PLEXIN SIGNALING PATHWAY |
14 |
36 |
1.707e-05 |
0.0002244 |
355 |
POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
17 |
50 |
1.782e-05 |
0.0002336 |
356 |
REGULATION OF DENDRITE DEVELOPMENT |
30 |
120 |
1.837e-05 |
0.0002401 |
357 |
WNT SIGNALING PATHWAY |
66 |
351 |
1.864e-05 |
0.0002426 |
358 |
REGULATION OF AXONOGENESIS |
38 |
168 |
1.866e-05 |
0.0002426 |
359 |
METANEPHROS DEVELOPMENT |
23 |
81 |
1.923e-05 |
0.0002492 |
360 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
36 |
156 |
1.931e-05 |
0.0002496 |
361 |
RESPONSE TO HYDROGEN PEROXIDE |
28 |
109 |
2.014e-05 |
0.0002596 |
362 |
LUNG ALVEOLUS DEVELOPMENT |
15 |
41 |
2.035e-05 |
0.0002616 |
363 |
RESPONSE TO CALCIUM ION |
29 |
115 |
2.11e-05 |
0.0002704 |
364 |
REGULATION OF CELL CELL ADHESION |
70 |
380 |
2.14e-05 |
0.0002736 |
365 |
RIBONUCLEOTIDE CATABOLIC PROCESS |
12 |
28 |
2.147e-05 |
0.0002736 |
366 |
CONNECTIVE TISSUE DEVELOPMENT |
42 |
194 |
2.16e-05 |
0.0002746 |
367 |
SENSORY ORGAN MORPHOGENESIS |
49 |
239 |
2.193e-05 |
0.000278 |
368 |
POSITIVE REGULATION OF HEMOPOIESIS |
37 |
163 |
2.199e-05 |
0.000278 |
369 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
103 |
616 |
2.323e-05 |
0.000293 |
370 |
RESPONSE TO METAL ION |
63 |
333 |
2.352e-05 |
0.0002958 |
371 |
NEPHRON EPITHELIUM DEVELOPMENT |
25 |
93 |
2.399e-05 |
0.0003008 |
372 |
NEURON MIGRATION |
28 |
110 |
2.416e-05 |
0.0003021 |
373 |
PROTEIN UBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
32 |
134 |
2.663e-05 |
0.0003321 |
374 |
CEREBRAL CORTEX DEVELOPMENT |
27 |
105 |
2.757e-05 |
0.000343 |
375 |
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY |
15 |
42 |
2.838e-05 |
0.0003521 |
376 |
CYCLIC NUCLEOTIDE CATABOLIC PROCESS |
9 |
17 |
2.965e-05 |
0.0003659 |
377 |
REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
9 |
17 |
2.965e-05 |
0.0003659 |
378 |
MAMMARY GLAND DEVELOPMENT |
29 |
117 |
2.988e-05 |
0.0003678 |
379 |
LEUKOCYTE CELL CELL ADHESION |
51 |
255 |
3.033e-05 |
0.0003715 |
380 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
40 |
184 |
3.034e-05 |
0.0003715 |
381 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
164 |
1079 |
3.048e-05 |
0.0003722 |
382 |
TUBE FORMATION |
31 |
129 |
3.101e-05 |
0.0003767 |
383 |
CELLULAR MACROMOLECULE LOCALIZATION |
184 |
1234 |
3.099e-05 |
0.0003767 |
384 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
32 |
135 |
3.118e-05 |
0.0003779 |
385 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
64 |
343 |
3.165e-05 |
0.0003825 |
386 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
41 |
191 |
3.315e-05 |
0.0003996 |
387 |
REGULATION OF PEPTIDE TRANSPORT |
51 |
256 |
3.381e-05 |
0.0004065 |
388 |
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
52 |
263 |
3.519e-05 |
0.0004209 |
389 |
REGULATION OF WNT SIGNALING PATHWAY |
59 |
310 |
3.517e-05 |
0.0004209 |
390 |
LEUKOCYTE ACTIVATION |
74 |
414 |
3.619e-05 |
0.0004318 |
391 |
GLIAL CELL DIFFERENTIATION |
32 |
136 |
3.644e-05 |
0.0004325 |
392 |
EYE MORPHOGENESIS |
32 |
136 |
3.644e-05 |
0.0004325 |
393 |
ORGAN GROWTH |
20 |
68 |
3.784e-05 |
0.0004468 |
394 |
NERVE DEVELOPMENT |
20 |
68 |
3.784e-05 |
0.0004468 |
395 |
RESPONSE TO OXYGEN LEVELS |
59 |
311 |
3.873e-05 |
0.0004563 |
396 |
RESPONSE TO ESTROGEN |
45 |
218 |
3.911e-05 |
0.0004596 |
397 |
POSITIVE REGULATION OF JUN KINASE ACTIVITY |
19 |
63 |
3.999e-05 |
0.0004687 |
398 |
METANEPHRIC MESENCHYME DEVELOPMENT |
8 |
14 |
4.068e-05 |
0.0004743 |
399 |
CAMP CATABOLIC PROCESS |
8 |
14 |
4.068e-05 |
0.0004743 |
400 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
17 |
53 |
4.205e-05 |
0.0004892 |
401 |
POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
31 |
131 |
4.26e-05 |
0.0004944 |
402 |
RESPONSE TO CYTOKINE |
115 |
714 |
4.304e-05 |
0.0004982 |
403 |
REGULATION OF DENDRITE MORPHOGENESIS |
21 |
74 |
4.407e-05 |
0.0005088 |
404 |
CELL CHEMOTAXIS |
36 |
162 |
4.554e-05 |
0.0005245 |
405 |
RESPONSE TO DRUG |
76 |
431 |
4.575e-05 |
0.0005257 |
406 |
NEGATIVE REGULATION OF OSSIFICATION |
20 |
69 |
4.77e-05 |
0.0005467 |
407 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
28 |
114 |
4.848e-05 |
0.0005543 |
408 |
REGULATION OF AXON GUIDANCE |
14 |
39 |
4.894e-05 |
0.0005568 |
409 |
REGULATION OF CATABOLIC PROCESS |
117 |
731 |
4.883e-05 |
0.0005568 |
410 |
ORGANIC HYDROXY COMPOUND METABOLIC PROCESS |
83 |
482 |
4.985e-05 |
0.0005657 |
411 |
RESPONSE TO ALCOHOL |
66 |
362 |
5.038e-05 |
0.0005704 |
412 |
RESPONSE TO PEPTIDE |
72 |
404 |
5.054e-05 |
0.0005708 |
413 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
15 |
44 |
5.316e-05 |
0.0005989 |
414 |
LYMPHOCYTE ACTIVATION |
63 |
342 |
5.4e-05 |
0.0006069 |
415 |
ALPHA BETA T CELL ACTIVATION |
17 |
54 |
5.499e-05 |
0.0006165 |
416 |
REGULATION OF HEART CONTRACTION |
45 |
221 |
5.531e-05 |
0.0006187 |
417 |
REGULATION OF CELL ACTIVATION |
83 |
484 |
5.781e-05 |
0.0006451 |
418 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
39 |
183 |
6.022e-05 |
0.0006703 |
419 |
REGULATION OF JUN KINASE ACTIVITY |
22 |
81 |
6.106e-05 |
0.0006781 |
420 |
POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS |
25 |
98 |
6.207e-05 |
0.000686 |
421 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
25 |
98 |
6.207e-05 |
0.000686 |
422 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY |
34 |
152 |
6.36e-05 |
0.0007012 |
423 |
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES |
26 |
104 |
6.461e-05 |
0.0007107 |
424 |
SECRETION BY CELL |
83 |
486 |
6.693e-05 |
0.0007345 |
425 |
REGULATION OF SMOOTH MUSCLE CONTRACTION |
18 |
60 |
6.844e-05 |
0.0007493 |
426 |
REGULATION OF BINDING |
54 |
283 |
6.879e-05 |
0.0007514 |
427 |
ALPHA BETA T CELL DIFFERENTIATION |
15 |
45 |
7.15e-05 |
0.0007773 |
428 |
SPROUTING ANGIOGENESIS |
15 |
45 |
7.15e-05 |
0.0007773 |
429 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
16 |
50 |
7.254e-05 |
0.0007868 |
430 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
34 |
153 |
7.306e-05 |
0.0007906 |
431 |
IN UTERO EMBRYONIC DEVELOPMENT |
58 |
311 |
7.37e-05 |
0.0007957 |
432 |
REGULATION OF CYTOSKELETON ORGANIZATION |
85 |
502 |
7.486e-05 |
0.0008064 |
433 |
REGULATION OF MUSCLE CONTRACTION |
33 |
147 |
7.511e-05 |
0.0008072 |
434 |
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY |
32 |
141 |
7.686e-05 |
0.0008241 |
435 |
MESENCHYMAL TO EPITHELIAL TRANSITION |
8 |
15 |
7.855e-05 |
0.0008382 |
436 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
27 |
111 |
7.848e-05 |
0.0008382 |
437 |
REGULATION OF RECEPTOR ACTIVITY |
28 |
117 |
7.938e-05 |
0.0008452 |
438 |
T CELL DIFFERENTIATION |
29 |
123 |
7.958e-05 |
0.0008454 |
439 |
REGULATION OF MULTICELLULAR ORGANISM GROWTH |
19 |
66 |
8.105e-05 |
0.0008591 |
440 |
HIPPO SIGNALING |
11 |
27 |
8.327e-05 |
0.00088 |
441 |
CELLULAR TRANSITION METAL ION HOMEOSTASIS |
21 |
77 |
8.341e-05 |
0.00088 |
442 |
CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT |
13 |
36 |
8.453e-05 |
0.0008897 |
443 |
ACTION POTENTIAL |
24 |
94 |
8.509e-05 |
0.0008897 |
444 |
RESPONSE TO BMP |
24 |
94 |
8.509e-05 |
0.0008897 |
445 |
CELLULAR RESPONSE TO BMP STIMULUS |
24 |
94 |
8.509e-05 |
0.0008897 |
446 |
REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY |
18 |
61 |
8.698e-05 |
0.0009054 |
447 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
18 |
61 |
8.698e-05 |
0.0009054 |
448 |
PEPTIDYL TYROSINE MODIFICATION |
39 |
186 |
8.731e-05 |
0.0009069 |
449 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
25 |
100 |
8.859e-05 |
0.000916 |
450 |
LIMBIC SYSTEM DEVELOPMENT |
25 |
100 |
8.859e-05 |
0.000916 |
451 |
ADRENAL GLAND DEVELOPMENT |
10 |
23 |
9.106e-05 |
0.0009354 |
452 |
PROTEIN TARGETING TO PLASMA MEMBRANE |
10 |
23 |
9.106e-05 |
0.0009354 |
453 |
TRABECULA FORMATION |
10 |
23 |
9.106e-05 |
0.0009354 |
454 |
NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE |
14 |
41 |
9.202e-05 |
0.000941 |
455 |
NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
14 |
41 |
9.202e-05 |
0.000941 |
456 |
POST EMBRYONIC DEVELOPMENT |
23 |
89 |
9.71e-05 |
0.0009908 |
457 |
REGULATION OF CELL GROWTH |
69 |
391 |
9.785e-05 |
0.0009963 |
458 |
LIPID METABOLIC PROCESS |
171 |
1158 |
9.925e-05 |
0.001008 |
459 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
24 |
95 |
0.0001019 |
0.001033 |
460 |
CIRCADIAN RHYTHM |
31 |
137 |
0.0001046 |
0.001059 |
461 |
SECRETION |
96 |
588 |
0.0001088 |
0.001096 |
462 |
REGULATION OF STEM CELL DIFFERENTIATION |
27 |
113 |
0.0001087 |
0.001096 |
463 |
SKELETAL SYSTEM MORPHOGENESIS |
41 |
201 |
0.0001112 |
0.001117 |
464 |
ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE |
23 |
90 |
0.0001167 |
0.00117 |
465 |
IMPORT INTO CELL |
13 |
37 |
0.000117 |
0.00117 |
466 |
EAR DEVELOPMENT |
40 |
195 |
0.000118 |
0.001178 |
467 |
MUSCLE SYSTEM PROCESS |
53 |
282 |
0.0001201 |
0.001196 |
468 |
MYELOID LEUKOCYTE DIFFERENTIATION |
24 |
96 |
0.0001215 |
0.001208 |
469 |
EPITHELIAL CELL MORPHOGENESIS |
14 |
42 |
0.0001238 |
0.001229 |
470 |
REGULATION OF WOUND HEALING |
29 |
126 |
0.0001256 |
0.001243 |
471 |
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
42 |
209 |
0.0001308 |
0.00129 |
472 |
LYMPHOCYTE DIFFERENTIATION |
42 |
209 |
0.0001308 |
0.00129 |
473 |
NEGATIVE REGULATION OF MAPK CASCADE |
32 |
145 |
0.0001346 |
0.001324 |
474 |
NEGATIVE REGULATION OF GROWTH |
46 |
236 |
0.0001372 |
0.001347 |
475 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
20 |
74 |
0.0001398 |
0.00137 |
476 |
REGULATION OF DEVELOPMENTAL PIGMENTATION |
8 |
16 |
0.0001416 |
0.001384 |
477 |
REGULATION OF PROTEIN SECRETION |
68 |
389 |
0.0001463 |
0.001424 |
478 |
NEGATIVE REGULATION OF JNK CASCADE |
12 |
33 |
0.0001462 |
0.001424 |
479 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
25 |
103 |
0.0001474 |
0.001429 |
480 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
25 |
103 |
0.0001474 |
0.001429 |
481 |
EMBRYONIC HEMOPOIESIS |
9 |
20 |
0.0001494 |
0.001445 |
482 |
LIPID LOCALIZATION |
50 |
264 |
0.0001516 |
0.001463 |
483 |
IRON ION HOMEOSTASIS |
19 |
69 |
0.0001557 |
0.0015 |
484 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
109 |
691 |
0.0001569 |
0.001509 |
485 |
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
13 |
38 |
0.0001596 |
0.001531 |
486 |
COGNITION |
48 |
251 |
0.0001602 |
0.001534 |
487 |
CELLULAR LIPID METABOLIC PROCESS |
138 |
913 |
0.0001663 |
0.001589 |
488 |
POSITIVE REGULATION OF PROTEIN IMPORT |
25 |
104 |
0.0001736 |
0.001656 |
489 |
FORMATION OF PRIMARY GERM LAYER |
26 |
110 |
0.0001743 |
0.001659 |
490 |
CARTILAGE DEVELOPMENT |
32 |
147 |
0.000176 |
0.001672 |
491 |
STEM CELL DIVISION |
11 |
29 |
0.0001785 |
0.001685 |
492 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
56 |
307 |
0.0001779 |
0.001685 |
493 |
MEMBRANE ORGANIZATION |
136 |
899 |
0.0001782 |
0.001685 |
494 |
POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION |
21 |
81 |
0.0001828 |
0.001722 |
495 |
CARBOHYDRATE DERIVATIVE METABOLIC PROCESS |
155 |
1047 |
0.0001854 |
0.001743 |
496 |
TISSUE REMODELING |
22 |
87 |
0.0001919 |
0.001801 |
497 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
29 |
129 |
0.000194 |
0.001816 |
498 |
POSITIVE REGULATION OF CELL GROWTH |
32 |
148 |
0.0002008 |
0.001872 |
499 |
RESPONSE TO TRANSITION METAL NANOPARTICLE |
32 |
148 |
0.0002008 |
0.001872 |
500 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
51 |
274 |
0.0002042 |
0.0019 |
501 |
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
40 |
200 |
0.0002074 |
0.001926 |
502 |
CARDIAC SEPTUM MORPHOGENESIS |
15 |
49 |
0.0002113 |
0.001959 |
503 |
ION TRANSPORT |
182 |
1262 |
0.0002119 |
0.00196 |
504 |
INTEGRIN MEDIATED SIGNALING PATHWAY |
21 |
82 |
0.00022 |
0.002031 |
505 |
MYELOID CELL HOMEOSTASIS |
22 |
88 |
0.0002291 |
0.002111 |
506 |
REGULATION OF ION HOMEOSTASIS |
40 |
201 |
0.0002313 |
0.002127 |
507 |
CHONDROCYTE DEVELOPMENT |
9 |
21 |
0.0002355 |
0.002157 |
508 |
REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS |
9 |
21 |
0.0002355 |
0.002157 |
509 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
31 |
143 |
0.0002384 |
0.002179 |
510 |
EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS |
8 |
17 |
0.0002411 |
0.002187 |
511 |
MAMMARY GLAND ALVEOLUS DEVELOPMENT |
8 |
17 |
0.0002411 |
0.002187 |
512 |
MAMMARY GLAND LOBULE DEVELOPMENT |
8 |
17 |
0.0002411 |
0.002187 |
513 |
REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
41 |
208 |
0.0002406 |
0.002187 |
514 |
SKELETAL MUSCLE ORGAN DEVELOPMENT |
30 |
137 |
0.0002478 |
0.002243 |
515 |
CRANIAL SKELETAL SYSTEM DEVELOPMENT |
16 |
55 |
0.0002539 |
0.002294 |
516 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
96 |
602 |
0.0002573 |
0.00232 |
517 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
18 |
66 |
0.0002621 |
0.00235 |
518 |
REGULATION OF VASOCONSTRICTION |
18 |
66 |
0.0002621 |
0.00235 |
519 |
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
18 |
66 |
0.0002621 |
0.00235 |
520 |
POST GOLGI VESICLE MEDIATED TRANSPORT |
21 |
83 |
0.0002637 |
0.00236 |
521 |
VASCULAR PROCESS IN CIRCULATORY SYSTEM |
34 |
163 |
0.0002658 |
0.002374 |
522 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
45 |
236 |
0.00027 |
0.002405 |
523 |
CELL MATRIX ADHESION |
27 |
119 |
0.0002707 |
0.002405 |
524 |
FACE DEVELOPMENT |
15 |
50 |
0.0002708 |
0.002405 |
525 |
EPITHELIAL CELL PROLIFERATION |
22 |
89 |
0.0002724 |
0.002415 |
526 |
CANONICAL WNT SIGNALING PATHWAY |
23 |
95 |
0.0002775 |
0.002455 |
527 |
MAINTENANCE OF LOCATION |
30 |
138 |
0.0002831 |
0.0025 |
528 |
RENAL TUBULE DEVELOPMENT |
20 |
78 |
0.0003024 |
0.002665 |
529 |
ENTRAINMENT OF CIRCADIAN CLOCK |
10 |
26 |
0.0003078 |
0.002702 |
530 |
HEART GROWTH |
10 |
26 |
0.0003078 |
0.002702 |
531 |
POSITIVE REGULATION OF CHEMOTAXIS |
27 |
120 |
0.0003124 |
0.002738 |
532 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
18 |
67 |
0.0003212 |
0.002809 |
533 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
32 |
152 |
0.0003336 |
0.002907 |
534 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
32 |
152 |
0.0003336 |
0.002907 |
535 |
IMMUNE RESPONSE |
160 |
1100 |
0.0003417 |
0.002972 |
536 |
REGULATION OF ORGAN GROWTH |
19 |
73 |
0.0003451 |
0.002996 |
537 |
RESPONSE TO ESTRADIOL |
31 |
146 |
0.0003506 |
0.003038 |
538 |
NEGATIVE REGULATION OF MUSCLE CONTRACTION |
9 |
22 |
0.0003588 |
0.0031 |
539 |
CARDIAC VENTRICLE MORPHOGENESIS |
17 |
62 |
0.0003591 |
0.0031 |
540 |
BONE MORPHOGENESIS |
20 |
79 |
0.0003627 |
0.003125 |
541 |
CELLULAR RESPONSE TO ALCOHOL |
26 |
115 |
0.0003693 |
0.003177 |
542 |
OLFACTORY LOBE DEVELOPMENT |
12 |
36 |
0.000374 |
0.003204 |
543 |
CORTICAL CYTOSKELETON ORGANIZATION |
12 |
36 |
0.000374 |
0.003204 |
544 |
CELL SUBSTRATE JUNCTION ASSEMBLY |
13 |
41 |
0.0003759 |
0.003215 |
545 |
SMALL MOLECULE METABOLIC PROCESS |
243 |
1767 |
0.0003842 |
0.003281 |
546 |
KIDNEY MESENCHYME DEVELOPMENT |
8 |
18 |
0.0003913 |
0.003328 |
547 |
CENTROSOME LOCALIZATION |
8 |
18 |
0.0003913 |
0.003328 |
548 |
SECOND MESSENGER MEDIATED SIGNALING |
33 |
160 |
0.0004022 |
0.003415 |
549 |
DIVALENT INORGANIC CATION TRANSPORT |
49 |
268 |
0.0004129 |
0.0035 |
550 |
NEGATIVE REGULATION OF SECRETION |
39 |
200 |
0.0004216 |
0.003566 |
551 |
ADULT LOCOMOTORY BEHAVIOR |
20 |
80 |
0.0004332 |
0.003658 |
552 |
MOTOR NEURON AXON GUIDANCE |
10 |
27 |
0.0004398 |
0.003694 |
553 |
NEGATIVE REGULATION OF AXON GUIDANCE |
10 |
27 |
0.0004398 |
0.003694 |
554 |
SUBSTRATE DEPENDENT CELL MIGRATION |
10 |
27 |
0.0004398 |
0.003694 |
555 |
REGULATION OF HORMONE SECRETION |
48 |
262 |
0.0004485 |
0.00376 |
556 |
MULTICELLULAR ORGANISMAL SIGNALING |
27 |
123 |
0.0004738 |
0.003965 |
557 |
GASTRULATION |
32 |
155 |
0.0004795 |
0.004006 |
558 |
METANEPHRIC NEPHRON DEVELOPMENT |
11 |
32 |
0.0004837 |
0.004019 |
559 |
POSITIVE REGULATION OF DENDRITE MORPHOGENESIS |
11 |
32 |
0.0004837 |
0.004019 |
560 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS |
11 |
32 |
0.0004837 |
0.004019 |
561 |
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS |
37 |
188 |
0.0004859 |
0.004031 |
562 |
SPECIFICATION OF SYMMETRY |
26 |
117 |
0.00049 |
0.004042 |
563 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
26 |
117 |
0.00049 |
0.004042 |
564 |
AUTONOMIC NERVOUS SYSTEM DEVELOPMENT |
13 |
42 |
0.0004889 |
0.004042 |
565 |
HOMEOSTASIS OF NUMBER OF CELLS |
35 |
175 |
0.0004999 |
0.00411 |
566 |
POSITIVE REGULATION OF AUTOPHAGY |
19 |
75 |
0.0004992 |
0.00411 |
567 |
NEURAL TUBE DEVELOPMENT |
31 |
149 |
0.0005073 |
0.004156 |
568 |
REGULATION OF LEUKOCYTE MIGRATION |
31 |
149 |
0.0005073 |
0.004156 |
569 |
ODONTOGENESIS |
24 |
105 |
0.0005153 |
0.004214 |
570 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
22 |
93 |
0.0005261 |
0.004295 |
571 |
CRANIAL NERVE MORPHOGENESIS |
9 |
23 |
0.000531 |
0.004327 |
572 |
CELL PROJECTION ASSEMBLY |
48 |
264 |
0.0005348 |
0.004348 |
573 |
RAS PROTEIN SIGNAL TRANSDUCTION |
30 |
143 |
0.0005355 |
0.004348 |
574 |
NEURON PROJECTION EXTENSION |
15 |
53 |
0.0005431 |
0.004402 |
575 |
URETER DEVELOPMENT |
6 |
11 |
0.0005628 |
0.004531 |
576 |
NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
6 |
11 |
0.0005628 |
0.004531 |
577 |
REGULATION OF FEVER GENERATION |
6 |
11 |
0.0005628 |
0.004531 |
578 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
105 |
684 |
0.000561 |
0.004531 |
579 |
LYSOSOMAL TRANSPORT |
18 |
70 |
0.0005728 |
0.004603 |
580 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
14 |
48 |
0.0005904 |
0.004729 |
581 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT |
14 |
48 |
0.0005904 |
0.004729 |
582 |
REGULATION OF CALCIUM MEDIATED SIGNALING |
19 |
76 |
0.0005964 |
0.004765 |
583 |
PROTEIN CATABOLIC PROCESS |
91 |
579 |
0.000597 |
0.004765 |
584 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
30 |
144 |
0.0006049 |
0.00482 |
585 |
PEPTIDYL TYROSINE DEPHOSPHORYLATION |
23 |
100 |
0.000608 |
0.004836 |
586 |
CELLULAR RESPONSE TO FLUID SHEAR STRESS |
8 |
19 |
0.0006094 |
0.004839 |
587 |
VENTRICULAR SEPTUM MORPHOGENESIS |
10 |
28 |
0.0006157 |
0.004856 |
588 |
REGULATION OF KERATINOCYTE PROLIFERATION |
10 |
28 |
0.0006157 |
0.004856 |
589 |
RECEPTOR MEDIATED ENDOCYTOSIS |
43 |
231 |
0.0006158 |
0.004856 |
590 |
MAMMARY GLAND DUCT MORPHOGENESIS |
10 |
28 |
0.0006157 |
0.004856 |
591 |
CRANIAL NERVE DEVELOPMENT |
13 |
43 |
0.0006294 |
0.004947 |
592 |
CEREBRAL CORTEX CELL MIGRATION |
13 |
43 |
0.0006294 |
0.004947 |
593 |
SPHINGOLIPID METABOLIC PROCESS |
29 |
138 |
0.0006382 |
0.004982 |
594 |
INTERFERON GAMMA PRODUCTION |
7 |
15 |
0.0006402 |
0.004982 |
595 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION |
7 |
15 |
0.0006402 |
0.004982 |
596 |
POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS |
7 |
15 |
0.0006402 |
0.004982 |
597 |
VENOUS BLOOD VESSEL DEVELOPMENT |
7 |
15 |
0.0006402 |
0.004982 |
598 |
AMINO ACID IMPORT |
7 |
15 |
0.0006402 |
0.004982 |
599 |
ORGANOPHOSPHATE CATABOLIC PROCESS |
25 |
113 |
0.0006674 |
0.005184 |
600 |
NEGATIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY |
24 |
107 |
0.000688 |
0.005335 |
601 |
CAMERA TYPE EYE MORPHOGENESIS |
23 |
101 |
0.0007048 |
0.005448 |
602 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
27 |
126 |
0.0007041 |
0.005448 |
603 |
METAL ION TRANSPORT |
91 |
582 |
0.0007066 |
0.005453 |
604 |
EMBRYONIC PLACENTA DEVELOPMENT |
20 |
83 |
0.0007206 |
0.005542 |
605 |
PROTEOGLYCAN METABOLIC PROCESS |
20 |
83 |
0.0007206 |
0.005542 |
606 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
31 |
152 |
0.0007229 |
0.00555 |
607 |
GLYCOPROTEIN METABOLIC PROCESS |
60 |
353 |
0.0007266 |
0.005569 |
608 |
POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
37 |
192 |
0.0007355 |
0.005629 |
609 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
16 |
60 |
0.0007408 |
0.005642 |
610 |
CHONDROCYTE DIFFERENTIATION |
16 |
60 |
0.0007408 |
0.005642 |
611 |
MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY |
16 |
60 |
0.0007408 |
0.005642 |
612 |
REGULATION OF HORMONE LEVELS |
77 |
478 |
0.0007453 |
0.005667 |
613 |
REGULATION OF ENDOCYTOSIS |
38 |
199 |
0.0007536 |
0.00572 |
614 |
POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION |
9 |
24 |
0.0007653 |
0.00579 |
615 |
REGULATION OF EMBRYONIC DEVELOPMENT |
25 |
114 |
0.0007651 |
0.00579 |
616 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
40 |
213 |
0.0007827 |
0.005912 |
617 |
REGULATION OF EXOCYTOSIS |
36 |
186 |
0.0007923 |
0.005946 |
618 |
NEGATIVE REGULATION OF PROTEIN SECRETION |
24 |
108 |
0.0007919 |
0.005946 |
619 |
MESODERM MORPHOGENESIS |
17 |
66 |
0.0007894 |
0.005946 |
620 |
MUCOPOLYSACCHARIDE METABOLIC PROCESS |
24 |
108 |
0.0007919 |
0.005946 |
621 |
RESPONSE TO TOXIC SUBSTANCE |
44 |
241 |
0.0008148 |
0.006086 |
622 |
NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION |
23 |
102 |
0.0008148 |
0.006086 |
623 |
RENAL SYSTEM PROCESS |
23 |
102 |
0.0008148 |
0.006086 |
624 |
MAINTENANCE OF LOCATION IN CELL |
22 |
96 |
0.0008327 |
0.006209 |
625 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
26 |
121 |
0.0008384 |
0.006242 |
626 |
NEGATIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS |
12 |
39 |
0.0008479 |
0.006272 |
627 |
REGULATION OF PHOSPHOLIPASE C ACTIVITY |
12 |
39 |
0.0008479 |
0.006272 |
628 |
REGULATION OF VACUOLAR TRANSPORT |
10 |
29 |
0.0008458 |
0.006272 |
629 |
ANATOMICAL STRUCTURE MATURATION |
12 |
39 |
0.0008479 |
0.006272 |
630 |
ALCOHOL METABOLIC PROCESS |
59 |
348 |
0.0008532 |
0.006301 |
631 |
ADHERENS JUNCTION ASSEMBLY |
11 |
34 |
0.0008674 |
0.006386 |
632 |
RENAL WATER HOMEOSTASIS |
11 |
34 |
0.0008674 |
0.006386 |
633 |
CELLULAR RESPONSE TO HYDROGEN PEROXIDE |
16 |
61 |
0.0009009 |
0.006622 |
634 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
27 |
128 |
0.0009073 |
0.006659 |
635 |
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
24 |
109 |
0.000909 |
0.006661 |
636 |
NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY |
8 |
20 |
0.0009161 |
0.006677 |
637 |
INTRACELLULAR LIPID TRANSPORT |
8 |
20 |
0.0009161 |
0.006677 |
638 |
ACTIN FILAMENT ORGANIZATION |
34 |
174 |
0.000917 |
0.006677 |
639 |
LYMPH VESSEL DEVELOPMENT |
8 |
20 |
0.0009161 |
0.006677 |
640 |
VISUAL BEHAVIOR |
14 |
50 |
0.0009253 |
0.006717 |
641 |
PURINE CONTAINING COMPOUND CATABOLIC PROCESS |
14 |
50 |
0.0009253 |
0.006717 |
642 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
65 |
393 |
0.0009361 |
0.006785 |
643 |
RESPONSE TO TEMPERATURE STIMULUS |
30 |
148 |
0.000968 |
0.007005 |
644 |
POSITIVE REGULATION OF CELL CELL ADHESION |
44 |
243 |
0.0009706 |
0.007012 |
645 |
HIPPOCAMPUS DEVELOPMENT |
18 |
73 |
0.0009782 |
0.007056 |
646 |
ENSHEATHMENT OF NEURONS |
21 |
91 |
0.000983 |
0.007069 |
647 |
AXON ENSHEATHMENT |
21 |
91 |
0.000983 |
0.007069 |
648 |
VACUOLE ORGANIZATION |
33 |
168 |
0.0009851 |
0.007073 |
649 |
DENDRITE DEVELOPMENT |
19 |
79 |
0.0009921 |
0.007086 |
650 |
MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS |
19 |
79 |
0.0009921 |
0.007086 |
651 |
PALATE DEVELOPMENT |
20 |
85 |
0.0009929 |
0.007086 |
652 |
HEART PROCESS |
20 |
85 |
0.0009929 |
0.007086 |
653 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
25 |
116 |
0.0009984 |
0.007114 |
654 |
L AMINO ACID IMPORT |
6 |
12 |
0.001019 |
0.007194 |
655 |
REGULATION OF DENDRITIC SPINE DEVELOPMENT |
15 |
56 |
0.001021 |
0.007194 |
656 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
15 |
56 |
0.001021 |
0.007194 |
657 |
OUTFLOW TRACT MORPHOGENESIS |
15 |
56 |
0.001021 |
0.007194 |
658 |
POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS |
6 |
12 |
0.001019 |
0.007194 |
659 |
CATABOLIC PROCESS |
240 |
1773 |
0.001022 |
0.007194 |
660 |
EMBRYONIC CAMERA TYPE EYE FORMATION |
6 |
12 |
0.001019 |
0.007194 |
661 |
REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY |
6 |
12 |
0.001019 |
0.007194 |
662 |
DEPHOSPHORYLATION |
50 |
286 |
0.001032 |
0.007253 |
663 |
POSITIVE REGULATION OF RESPONSE TO WOUNDING |
32 |
162 |
0.001057 |
0.007418 |
664 |
PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
9 |
25 |
0.001077 |
0.00755 |
665 |
RESPONSE TO CAMP |
23 |
104 |
0.00108 |
0.007556 |
666 |
DEVELOPMENTAL PIGMENTATION |
12 |
40 |
0.001089 |
0.007595 |
667 |
NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
12 |
40 |
0.001089 |
0.007595 |
668 |
AMMONIUM ION METABOLIC PROCESS |
33 |
169 |
0.001095 |
0.007613 |
669 |
REGULATION OF BLOOD PRESSURE |
33 |
169 |
0.001095 |
0.007613 |
670 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
22 |
98 |
0.001114 |
0.007724 |
671 |
LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE |
22 |
98 |
0.001114 |
0.007724 |
672 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
17 |
68 |
0.001134 |
0.007854 |
673 |
NEURON MATURATION |
10 |
30 |
0.001142 |
0.00786 |
674 |
POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS |
14 |
51 |
0.001145 |
0.00786 |
675 |
NEGATIVE REGULATION OF CHEMOTAXIS |
14 |
51 |
0.001145 |
0.00786 |
676 |
REGULATION OF NEURON MIGRATION |
10 |
30 |
0.001142 |
0.00786 |
677 |
REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
21 |
92 |
0.001141 |
0.00786 |
678 |
REGULATION OF DENDRITIC SPINE MORPHOGENESIS |
10 |
30 |
0.001142 |
0.00786 |
679 |
ORGANOPHOSPHATE METABOLIC PROCESS |
129 |
885 |
0.001152 |
0.007894 |
680 |
CELL CELL JUNCTION ASSEMBLY |
18 |
74 |
0.001159 |
0.00793 |
681 |
NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT |
19 |
80 |
0.001166 |
0.007956 |
682 |
CELLULAR RESPONSE TO MECHANICAL STIMULUS |
19 |
80 |
0.001166 |
0.007956 |
683 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
69 |
426 |
0.001177 |
0.008019 |
684 |
HINDBRAIN DEVELOPMENT |
28 |
137 |
0.001231 |
0.008372 |
685 |
CIRCADIAN REGULATION OF GENE EXPRESSION |
15 |
57 |
0.001243 |
0.008444 |
686 |
EPIDERMIS DEVELOPMENT |
45 |
253 |
0.00125 |
0.00848 |
687 |
CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS |
44 |
246 |
0.001253 |
0.008489 |
688 |
MEMBRANE LIPID METABOLIC PROCESS |
35 |
184 |
0.001277 |
0.008634 |
689 |
MESODERM DEVELOPMENT |
25 |
118 |
0.001291 |
0.008718 |
690 |
REGULATION OF CARTILAGE DEVELOPMENT |
16 |
63 |
0.00131 |
0.008821 |
691 |
RESPONSE TO OSMOTIC STRESS |
16 |
63 |
0.00131 |
0.008821 |
692 |
NEGATIVE REGULATION OF ORGAN GROWTH |
8 |
21 |
0.001335 |
0.008963 |
693 |
ZINC ION HOMEOSTASIS |
8 |
21 |
0.001335 |
0.008963 |
694 |
NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS |
17 |
69 |
0.00135 |
0.009025 |
695 |
PERIPHERAL NERVOUS SYSTEM DEVELOPMENT |
17 |
69 |
0.00135 |
0.009025 |
696 |
POSITIVE REGULATION OF AXONOGENESIS |
17 |
69 |
0.00135 |
0.009025 |
697 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
18 |
75 |
0.001367 |
0.009127 |
698 |
REGULATION OF LIPID STORAGE |
12 |
41 |
0.001384 |
0.009172 |
699 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
12 |
41 |
0.001384 |
0.009172 |
700 |
NEGATIVE REGULATION OF CELL CELL ADHESION |
28 |
138 |
0.001382 |
0.009172 |
701 |
AORTA DEVELOPMENT |
12 |
41 |
0.001384 |
0.009172 |
702 |
PLACENTA DEVELOPMENT |
28 |
138 |
0.001382 |
0.009172 |
703 |
REGULATION OF FAT CELL DIFFERENTIATION |
23 |
106 |
0.001416 |
0.009374 |
704 |
PROTEIN AUTOPHOSPHORYLATION |
36 |
192 |
0.001431 |
0.009461 |
705 |
SYNAPSE ORGANIZATION |
29 |
145 |
0.001449 |
0.009561 |
706 |
POSITIVE REGULATION OF PROTEOLYSIS |
60 |
363 |
0.001459 |
0.009618 |
707 |
REGULATION OF LEUKOCYTE PROLIFERATION |
38 |
206 |
0.001465 |
0.009644 |
708 |
POSITIVE REGULATION OF AXON EXTENSION |
11 |
36 |
0.001474 |
0.009672 |
709 |
HEAD MORPHOGENESIS |
11 |
36 |
0.001474 |
0.009672 |
710 |
HEART TRABECULA MORPHOGENESIS |
9 |
26 |
0.001485 |
0.009703 |
711 |
MESODERMAL CELL DIFFERENTIATION |
9 |
26 |
0.001485 |
0.009703 |
712 |
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION |
9 |
26 |
0.001485 |
0.009703 |
713 |
ADULT WALKING BEHAVIOR |
10 |
31 |
0.001518 |
0.009864 |
714 |
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION |
10 |
31 |
0.001518 |
0.009864 |
715 |
MATERNAL PLACENTA DEVELOPMENT |
10 |
31 |
0.001518 |
0.009864 |
716 |
WALKING BEHAVIOR |
10 |
31 |
0.001518 |
0.009864 |
717 |
NEURAL TUBE FORMATION |
21 |
94 |
0.001523 |
0.009872 |
718 |
POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
34 |
179 |
0.001523 |
0.009872 |
719 |
TRANSMEMBRANE TRANSPORT |
155 |
1098 |
0.001541 |
0.009975 |